Hologic Trading Near 52-Week High: How Should You Play the Stock? [Yahoo! Finance]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Yahoo! Finance
In the past six months, the company has gained 15.9%, outperforming its industry and sector, while the proposed $18.3 billion-take-private deal by Blackstone and TPG continued to draw widespread focus. At current levels, the transaction implies roughly a 1.9% upside potential to the $76 offer, assuming stockholder approval and other customary closing conditions ahead of the expected completion in the first half of 2026. The stock also surpassed the S&P 500 composite, which rallied 13% in the same period. Among its major competitors, Abbott ABT fell 7.1%, while CooperCompanies COO rose 10.7%, both trailing behind Hologic's performance. Image Source: Zacks Investment Research From a technical standpoint, HOLX stock is trading above its 50-day and 200-day moving averages, suggesting robust investor confidence. Image Source: Zacks Investment Research The company continues to benefit from Molecular Diagnostics, comprising a wide range of assays that run on the Panther and the Pan
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Rep. Julia Letlow Discloses Over 200 Stock Trades After Deadline As Ban Debate Grows In Congress [Forbes]Forbes
- Abbott Laboratories (NYSE:ABT) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $157.00 to $152.00. They now have a "buy" rating on the stock.MarketBeat
- AI Optical Coherence Tomography Market Opportunities to 2029 & 2034 by Type, Technology, Application and Region [Yahoo! Finance]Yahoo! Finance
- Why Abbott Laboratories (ABT) Story Is Shifting With Exact Sciences Deal Talk And Legal Wins [Yahoo! Finance]Yahoo! Finance
- PainTEQ Announces Appointment of Lalit Venkatesan, PhD as Senior Vice President of Clinical Research [Yahoo! Finance]Yahoo! Finance
ABT
Earnings
- 10/15/25 - In-Line
ABT
Sec Filings
- 1/5/26 - Form 4
- 1/5/26 - Form 4
- 1/5/26 - Form 4
- ABT's page on the SEC website